Pathstone Holdings’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$519K Buy
18,879
+2,721
+17% +$89.4K ﹤0.01% 1856
2026
Q1
$602K Sell
16,158
-1,735
-10% -$71.5K ﹤0.01% 1664
2025
Q4
$837K Buy
17,893
+1,528
+9% +$66.1K ﹤0.01% 1510
2025
Q3
$686K Buy
16,365
+1,842
+13% +$81K ﹤0.01% 1608
2025
Q2
$639K Sell
14,523
-3,942
-21% -$179K ﹤0.01% 1599
2025
Q1
$930K Buy
18,465
+1,362
+8% +$67.5K ﹤0.01% 1418
2024
Q4
$735K Sell
17,103
-71
-0.4% -$3K ﹤0.01% 1528
2024
Q3
$673K Sell
17,174
-836
-5% -$30.2K ﹤0.01% 1584
2024
Q2
$580K Sell
18,010
-9,267
-34% -$299K ﹤0.01% 1611
2024
Q1
$899K Buy
+27,277
New +$948K ﹤0.01% 1345

Other funds holding G

Pathstone Holdings's G Position: Q2 2026 in Review

Pathstone Holdings increased its Genpact (G) stake by 17% in Q2 2026, buying an estimated $89.4K and bringing the position to 18,879 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Pathstone Holdings first reported a position in G in Q1 2024 and has held it in 10 quarters since. The position peaked at $930K in Q1 2025. 478 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Pathstone Holdings held 18,879 shares of Genpact worth $519K as of Q2 2026.
  • Pathstone Holdings bought 2,721 Genpact shares in Q2 2026, an estimated $89.4K.
  • Genpact made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1856 holding.
  • Pathstone Holdings first reported a position in Genpact in Q1 2024 and has held it in 10 quarters since.
  • Pathstone Holdings's Genpact position peaked at $930K in Q1 2025.
  • 478 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.